Expert Biotechnology Market Analysts Consultants

With a PhD in molecular genetics and as a specialist in data science, Céline Chantry-Darmon has over twenty years of experience in biomedical research and complex data analysis. As Scientific Director at Tekkare, she works on developing trustworthy artificial intelligence for healthcare. She is also committed to promoting inclusive and responsible artificial intelligence, and to advancing women in science and technology.

Drik Diglar is an automotive SEO and digital marketing analyst focused on how search, AI, and buyer behavior are reshaping the car buying journey. He studies dealership websites, traffic patterns, and lead generation systems to uncover why some dealerships dominate online visibility while others struggle to generate consistent leads. His insights focus on the intersection of search intent, website structure, and conversion strategy in the modern automotive market.

AI meets biotech — straight from Zug, Switzerland Get the latest AI news, learn must-know AI tools, and keep up with Biotech news in just 5 minutes a week. Join our readers growing their careers with the AIxBiotech newsletter. Founded by executives who have led global biotech and tech teams, AIxBiotech is on a mission to make AI practical for themodern biotech office. In just a few months, we’ve attracted a fast-growing audience of biotech professionals and innovation leaders — from early-stage founders to Fortune 500 executives. Our readers span Europe and North America, with a strong base in the U.S. and Switzerland. We’re building organically, one engaged reader at a time — with the ambition to reach 500K professionals within our first year.

Skilled, highly knowledgeable, and analytical professional with over fourteen years experience in the healthcare sector. Primary expertise in providing strategic insights and actionable information to life science companies. Proficient in molecular diagnostics, point of care diagnostics, genomics, immunoassays, oncology diagnostics, cardiology diagnostics, infectious disease diagnostics and personalized medicine. Strong ability in capturing customer insights, performing technical analysis, sizing niche segments, financial modeling, evaluating market dynamics, identify/evaluate new product potential, and presenting high impact, tactical recommendations. Specialties: Extensive knowledge in the genomics, in-vitro diagnostics space. Demonstrated success in managing teams and clients, assessing business models identifying market opportunities/risks and developing strategies to optimize market penetration, competitive advantage and profit.

I'm a digital marketer who lives at the intersection of creativity and strategy. For 6+ years, I’ve been crafting campaigns that don’t just grab attention—they deliver results. From SEO that ranks to social media that connects, and ads that convert, I turn ideas into impactful outcomes. I believe in the power of data to tell stories, using tools like Zoho Analytics to uncover insights and optimize strategies that drive measurable growth. What fuels me? Turning complex challenges into seamless marketing solutions. Whether it’s designing integrated campaigns, building brands online, or diving deep into analytics, I thrive on making marketing smarter, faster, and more effective. What I Bring to the Table: Growth-focused strategies * Storytelling that sells Websites that work Insights from data Let’s transform your marketing into a growth engine—one campaign at a time.

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

Authentic technology recruitment leader with expertise in executive talent acquisition and building high performance recruitment teams, primarily within the tech/digital/creative disciplines.

Food Research Lab is a Global Advanced Contract Research, Development and Pilot Manufacturing Organization (CDMO) that provides solutions to the Food, Beverage, Nutraceuticals, cosmeceutical, Pet food & Agriculture sectors worldwide.

✨ Nalini bring's clarity to chaos. For the past decade, she's turned early-stage climate and ag tech ideas into market leaders—most recently taking Planet FWD from concept to Series A funded. Nalini helps technical founders translate their vision into products customers will pay for. She has led product at Fortune 500s (Bayer's Climate Corp, Corteva's Granular) and scrappy startups, and knows exactly what works at each stage. Nalini is also known to leverage the latest AI tools to help early-stage teams do more with less, teaching teams these workflows so the impact compounds. As a mother of two young kids, Nalini has established herself as a career executive who deeply cares about balancing motherhood with her career. Learn more about Nalini: LinkedIn: https://www.linkedin.com/in/nalinigupta/ Substack Newsletter: https://nalinigeorge.substack.com/

Founder of IngredientMD, a supplement intelligence platform powdered by most clinical data available. What's important, we communicate in language humans will understand instead. It all starts from individual ingredients instead of product name, claims, and anything else. Product is what's inside instead of what perception is being made. In our analysis of 500+ supplement products, we found 42% had at least one key ingredient below clinically studied doses. I focus on bringing evidence-based analysis to consumer supplement decisions.

Andrea is an entrepreneur & global expert in 𝐬𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲, 𝐠𝐫𝐞𝐞𝐧 𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐞𝐧𝐞𝐫𝐠𝐲 𝐭𝐫𝐚𝐧𝐬𝐢𝐭𝐢𝐨𝐧. He is the founder & "Chief Earth Officer" (i.e. a CEO on a mission for our planet) at 𝐢𝐥𝐥𝐮𝐦𝐢𝐧𝐞𝐦.𝐜𝐨𝐦, a leading sustainability information and data platform, and one of Angel List’s ‘𝐓𝐨𝐩 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐒𝐭𝐚𝐫𝐭𝐮𝐩 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞’. In 2024, illuminem achieved "the most participated round by key climate investors worldwide" and "the region's highest valuation for an early-stage climate company". Andrea is also the 𝐲𝐨𝐮𝐧𝐠𝐞𝐬𝐭 𝐩𝐫𝐨𝐟. 𝐚𝐭 𝐇𝐄𝐂 𝐏𝐚𝐫𝐢𝐬 (Europe's #1 business school), where he teaches Europe’s only Greentech course, with the goal of developing the next generation of sustainability leaders. Previous to illuminem, he served as the 𝐁𝐨𝐬𝐭𝐨𝐧 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠 𝐆𝐫𝐨𝐮𝐩’𝐬 (𝐁𝐂𝐆) 𝐆𝐥𝐨𝐛𝐚𝐥 𝐆𝐫𝐞𝐞𝐧 𝐂𝐡𝐚𝐦𝐩𝐢𝐨𝐧, leading projects on sustainable investments and innovation for multinationals & governments. Andrea has been recognized by the 𝐔𝐧𝐢𝐭𝐞𝐝 𝐍𝐚𝐭𝐢𝐨𝐧𝐬 as one of the 50 𝐆𝐥𝐨𝐛𝐚𝐥 '𝐈𝐦𝐩𝐚𝐜𝐭 𝐌𝐚𝐤𝐞𝐫𝐬' ("civil society leaders making the change we need to see"), and by Startup Italia as one of '𝐈𝐭𝐚𝐥𝐲’𝐬 𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐨𝐫𝐬'. He is the Sustainability & Innovation 𝐂𝐨𝐥𝐮𝐦𝐧𝐢𝐬𝐭 𝐟𝐨𝐫 𝐀𝐮𝐬𝐭𝐫𝐢𝐚’𝐬 𝐦𝐚𝐢𝐧 𝐧𝐞𝐰𝐬𝐩𝐚𝐩𝐞𝐫, Der Standard; a published author in the Journal of Financial Engineering; and a speaker at events hosted by COP, Davos, and universities around the world. His latest TEDx on ESG has become “the most-watched talk in Italian on sustainability.”

Collin Hogue-Spears is the Senior Director, DTE, at Black Duck Software, leading FedRAMP authorization and federal cybersecurity compliance. He has 20+ years in technology, including Senior Program Manager for AWS GovCloud, where he protected $3B in public-sector revenue. Quoted in Politico, Dark Reading, CSO Online, and CPO Magazine on nation-state cyber operations, agentic AI security risks, and software supply chain compromise. His analysis focuses on state-sponsored supply chain campaigns and the governance gaps created by autonomous AI agents with enterprise access. He speaks intermediate Mandarin Chinese and tracks PRC cyber and AI strategy through primary-source government documents. CISSP | CISM | MBA, UMass Amherst

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

I write analysis on geoeconomics and the dollar at Hegemoney.com I am the Chief Economist at Column, a nationally chartered bank and technology company in San Francisco. For thirteen years I served as a senior economist at the Departments of Treasury, State, and the CIA. I am also a former FX strategist and derivatives trader. I have years of experience in sanctions, international currencies, financial infrastructure (SWIFT, international payment systems), tech, and macro conditions around the dollar.

As GRC strategist, I advise small and medium-sized enterprises on aligning IT security, regulatory mandates (DSGVO, BSI, NIS 2) and digital business processes. With hands-on experience in embedding compliance into business operations, I can deliver actionable quotes, commentary and thought-leadership for your coverage

Rebecca Gaisie is a top researcher at EIU and an Operations & Performance Improvement Professional at the intersection of energy transition and environmental compliance. She is the first-place recipient of the 2025 Award for Excellence in Research for her pioneering work in developing markets and the strategic implementation of UN Sustainable Development Goals (SDGs). Leveraging advanced data analytics and techno-economic modeling, Rebecca transforms complex operational streams into scalable, 'closed-loop' systems. Her work is dedicated to bridging the gap between high-level energy policy and ground-level operational efficiency, ensuring that global sustainable transitions are not only environmentally sound but economically viable and operationally superior."

Founder of RawPickAI, an independent AI tool review platform that has tested 47+ AI tools hands-on. Every review follows a rigorous methodology: Hands-on testing before every review, transparent scoring across 5 dimensions (0-100 scale), and pricing shown in both USD and INR. RawPickAI is one of the only AI review platforms built with the Indian market in mind, making it a go-to resource for founders, students, and professionals evaluating AI tools on a budget. I write about AI tool comparisons, pricing trends, and practical adoption strategies — particularly for emerging markets.

Achal Shah is VP of Strategic Development at Monetrey Mushrooms, a food and biotech company in the agriculture space, and a published contributor to AgFunderNews. With over 10 years of experience at the intersection of food, agriculture, and innovation, Achal has advised leading agribusinesses at McKinsey & Company and served as Global Strategy Lead and Chief of Staff to the CEO at RiceTec, a global seed company operating across the U.S., India, and Brazil. He has led strategies spanning seed genetics, sustainable farming, agri-biotech commercialization, digital transformation, and M&A — and spearheaded a multi-continent initiative to drive hybrid rice adoption that reduced methane emissions, cut water consumption, and improved profitability for smallholder farmers. Achal holds an MBA from the Kellogg School of Management and a Master’s in Design Innovation from Northwestern University. He is available to comment on agribusiness strategy, agricultural biotech, food system innovation, sustainable farming, and emerging trends shaping the global agriculture industry.

Ganesh Ariyur is a global enterprise technology executive and a Top 100 Digital Adoption Leader for 2025. He is known for delivering more than $500M in measurable enterprise value through large-scale digital transformation, enterprise systems modernization, cloud strategy, artificial intelligence adoption, data governance, & enterprise architecture leadership. His work spans more than 90 countries across Fortune 500 organizations, private-equity owned companies, and highly regulated industries. Ganesh serves as the Global Head of Enterprise Technology Strategy and Transformation at Gainwell Technologies, a $3B healthcare technology organization. He directs modernization programs across SAP S/4HANA, Oracle Cloud ERP, PeopleSoft, cloud platforms on AWS and Azure, enterprise applications, reporting and analytics, generative AI, intelligent automation, enterprise architecture, IT governance, and cybersecurity, aligned with operating models. His programs have delivered multi-million-dollar cost savings. He has directed enterprise portfolios valued at more than $1B. He has unified 450-plus legacy systems, led technology programs supporting more than $30B in M&A value, and guided organizations through complex TSA exits and carve-outs. Ganesh brings deep expertise in artificial intelligence-enabled operating models, multi-ERP modernization including SAP S/4 HANA, Oracle Cloud, & Workday, cloud strategy and FinOps, enterprise architecture, data, infrastructure, cybersecurity improvement, data quality & analytics modernization, robotic process automation & intelligent automation, shared services/global business services, organizational design, and long-term value creation. His people-process-technology approach led to his being named a Global Top 100 Digital Adoption Leader. He is a Certified AI Business Transformation Practitioner & a Certified Technology Innovation Practitioner. He is also a member of the Forbes Technology Council. He was publicly recognized for global transformation leadership when he was featured on billboards across Germany during a major enterprise program at Bayer. Ganesh is known for partnering with boards, CEOs, CFOs, & private equity operating teams. He aligns technology strategy with growth objectives, cost discipline, compliance needs, & long-term enterprise value. Based in Atlanta, he is regarded as a CIO leader who turns complexity into clarity and who consistently converts technology investment into measurable business outcomes.